The association between insulin resistance and hepatic fibrosis in patients with chronic hepatitis C: An observational, multicenter study in Turkey

Turkish Journal of Gastroenterology

Volumn 25, Issue 5, 2014, Pages 546-552

  Dökmeci, Abdulkadir ^a   Üstündaʇ, Yücel ^b   Hulagu, Saadettin ^c   Tuncer, Ilyas ^d   Akdoʇan, Meral ^e   Demirsoy, Hüseyin ^f   Köklü, Seyfettin ^g   Güzelbulut, Fatih ^h   Doʇan, Ibrahim ⁱ   Demir, Ali ^j   Akarsu, Mesut ^k   Yüceyar, Hakan ^l   Özdogan, Osman Cavit ^m   Özdener, Fatih ⁿ   Erdoʇan, Seda ⁿ  

^a ANKARA UNIVERSITY   (Turkey)

^b Zonguldak Karaelmas Universitesi Tip Fakultesi   (Turkey)

^c KOCAELI UNIVERSITY   (Turkey)

^d GOZTEPE TRAINING AND RESEARCH HOSPITAL   (Turkey)

^e TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

^f Adapazari Sakarya Turkey Seker Mah   (Turkey)

^g ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^h GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

ⁱ GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^j SELCUK UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^k DOKUZ EYLUL UNIVERSITY   (Turkey)

^l CELAL BAYAR UNIVERSITY MEDICAL FACULTY   (Turkey)

^m MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

ⁿ Roche Pharmaceuticals   (Turkey)

more..

Author keywords

Chronic hepatitis C; Hepatic fibrosis; Insulin resistance

Indexed keywords

ALANINE AMINOTRANSFERASE; GLUCOSE BLOOD LEVEL; INSULIN; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL EVALUATION; COMORBIDITY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GLUCOSE TOLERANCE; HEPATITIS C; HUMAN; HUMAN TISSUE; INSULIN RESISTANCE; LIVER BIOPSY; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; TURKEY (REPUBLIC); ANALYSIS OF VARIANCE; BLOOD; CHRONIC HEPATITIS C; CLINICAL TRIAL; COMPLICATION; DIET RESTRICTION; GENETICS; GLUCOSE BLOOD LEVEL; HEPACIVIRUS; HOMEOSTASIS; LIVER CIRRHOSIS; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; TURKEY; VIROLOGY; VIRUS LOAD;

ADULT; ALANINE TRANSAMINASE; ANALYSIS OF VARIANCE; BLOOD GLUCOSE; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RNA, VIRAL; TURKEY; VIRAL LOAD;

EID: 84909982945     PISSN: 13004948     EISSN: 21485607     Source Type: Journal    
DOI: 10.5152/tjg.2014.7829     Document Type: Article

References (27)

1. Gumber SC, Chopra S. Hepatitis C: A multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995; 123: 615-20
2. Simonetti RG, Cammà C, Fiorello F, et al. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. A case-control study. Ann Intern Med 1992; 116: 97-102
3. Mehta SH, Brancati FL, Sulkowski MS, et al. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000; 133: 592-9
4. Negro F. Mechanisms of hepatitis C virus-related insulin resistance. Clin Res Hepatol Gastroenterol 2011; 35: 358-63.
5. Shintani Y, Fujie H, Miyoshi H, et al. Hepatitis C virus infection and diabetes: direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004; 126: 840-8
6. Moucari R, Asselah T, Cazals-Hatem D, et al. Insulin resistance in chronic hepatitis C: Association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology 2008; 134: 416-23.
7. Kukla M, Mazur W, Buldak RJ, et al. Potential role of leptin, adiponectin and three novel adipokines - visfatin, chemerin and vaspin - in chronic hepatitis. Mol Med 2011; 17: 1397-410
8. Monto A, Alonzo J, Watson JJ, Grunfeld C, Wright TL. Steatosis in chronic hepatitis C: relative contributions of obesity, diabetes mellitus and alcohol. Hepatology 2002; 36: 729-36
9. Mohamed HR, Abdel-Azziz MY, Zalata KR, Abdel-Razik AM. Relation of insulin resistance and liver fibrosis progression in patients with chronic hepatitis C virus infection. Int J Health Sci (Qassim) 2009; 3: 177-86
10. Ratziu V, Munteanu M, Charlotte F, Bonyhay L, Poynard T; LIDO Study Group. Fibrogenic impact of high serum glucose in chronic hepatitis C. J Hepatol 2003; 39: 1049-55
11. Kawaguchi T, Sata M. Importance of hepatitis C virus-associated insulin resistance: therapeutic strategies for insulin sensitization. World J Gastroenterol 2010; 16: 1943-52
12. Lecube A, Hernández C, Genescà J, Simó R. Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: A case-control study. Diabetes Care 2006; 29: 1096-101
13. Lecube A, Hernández C, Genescà J, Simó R. Glucose abnormalities in patients with hepatitis C virus infection: Epidemiology and pathogenesis. Diabetes Care 2006; 29: 1140-9
14. Aksu HSZ, Kurtaran B, Onlen Y, et al. Association of insulin resistance, viral load, and adipokine levels with liver histology in patients with chronic hepatitis C: An observational, multicenter study in Turkey. Eur J Gastroenterol Hepatol 2012; 24: 1393-9.
15. Gunsar F, Akarca U, Ersoz G, et al. Kronik hepatit C virüs (HCV) enfeksiyonunda glukoz intoleransi ve glukoz yüklemeye insülin C-peptid yaniti. Turkiye Klinikleri J Int Med Sci 1999; 10: 105-12
16. Bedossa P, Poynard T. An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group. Hepatology 1996; 24: 289-93
17. Conjeevaram HS, Wahed AS, Afdhal N, et al. Virahep-C Study Group. Changes in insulin sensitivity and body weight during and after peginterferon and ribavirin therapy for hepatitis C. Gastroenterology 2011; 140: 469-77
18. Wang CS, Wang ST, Yao WJ, Chang TT, Chou P. Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study. Am J Epidemiol 2007; 166: 196-203
19. Petta S. Insulin resistance and diabetes mellitus in patients with chronic hepatitis C: spectators or actors? Dig Liver Dis 2012; 44: 359-60.
20. Ortiz V, Berenguer M, Rayón JM, Carrasco D, Berenguer J. Contribution of obesity to hepatitis C-related fibrosis progression. Am J Gastroenterol 2002; 97: 2408-14
21. Hui JM, Sud A, Farrell GC, et al. Insulin resistance is associated with chronic hepatitis C virus infection and fibrosis progression [corrected]. Gastroenterology 2003; 125: 1695-704
22. Hickman IJ, Powell EE, Prins JB, et al. In overweight patients with chronic hepatitis C, circulating insulin is associated with hepatic fibrosis: implications for therapy. J Hepatol 2003; 39: 1042-8
23. Petit JM, Bour JB, Galland-Jos C, et al. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepatol 2001; 35: 279-83
24. El Ray A, Asselah T, Moucari R, et al. Insulin resistance: A major factor associated with significant liver fibrosis in Egyptian patients with genotype 4 chronic hepatitis C. Eur J Gastroenterol Hepatol 2013; 25: 421-7
25. Ziada DH, El Saadany S, Enaba M, Ghazy M, Hasan A. The interaction between insulin resistance, liver fibrosis and early virological response in Egyptian patients with chronic hepatitis C. Can J Gastroenterol. 2012; 26: 325-9
26. Yoneda M, Saito S, Ikeda T, et al. Hepatitis C virus directly associates with insulin resistance independent of the visceral fat area in nonobese and nondiabetic patients. J Viral Hepat 2007; 14: 600-7
27. Fartoux L, Poujol-Robert A, Guéchot J, Wendum D, Poupon R, Serfaty L. Insulin resistance is a cause of steatosis and fibrosis progression in chronic hepatitis C. Gut 2005; 54: 1003-8.